Celldex Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Celldex Therapeutics, Inc. (CLDX) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount of $11.81 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCreditsResearch · last filed 2026-02-25
- Celldex Therapeutics, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2025 was $11.81M, a 61.06% increase from fiscal 2024.
- Celldex Therapeutics, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2024 was $7.33M, a 40.00% increase from fiscal 2023.
- Celldex Therapeutics, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2023 was $5.24M, a 35.11% increase from fiscal 2022.
- Celldex Therapeutics, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2022 was $3.88M, a 60.03% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month |
|---|---|
| 2025-12-31 | $11.81M 10-K · filed 2026-02-25 |
| 2024-12-31 | $7.33M 10-K · filed 2026-02-25 |
| 2023-12-31 | $5.24M 10-K · filed 2026-02-25 |
| 2022-12-31 | $3.88M 10-K · filed 2025-02-27 |
| 2021-12-31 | $2.42M 10-K · filed 2024-02-26 |
| 2020-12-31 | $1.78M 10-K · filed 2023-02-28 |
| 2019-12-31 | $1.90M 10-K · filed 2022-02-28 |
| 2018-12-31 | $2.06M 10-K · filed 2021-03-29 |
| 2017-12-31 | $2.85M 10-K · filed 2020-03-26 |
| 2016-12-31 | $5.20M 10-K · filed 2019-03-07 |
| 2015-12-31 | $4.93M 10-K · filed 2018-03-07 |
| 2014-12-31 | $4.13M 10-K · filed 2017-03-14 |
| 2013-12-31 | $3.26M 10-K/A · filed 2016-02-25 |
| 2011-12-31 | $1.74M 10-K · filed 2014-03-03 |
| 2010-12-31 | $1.50M 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |